Minerva Neurosciences, Inc. (NERV)

FARO Technologies Statistics

Total Valuation

NERV has a market cap or net worth of $13.37 million. The enterprise value is $56.08 million.

Market Cap	13.37M
Enterprise Value	56.08M

Important Dates

The next estimated earnings date is Tuesday, August 12, 2025, before market open.

Earnings Date	Aug 12, 2025
Ex-Dividend Date	n/a

Share Statistics

NERV has 6.99 million shares outstanding. The number of shares has increased by 7.22% in one year.

Current Share Class	6.99M
Shares Outstanding	6.99M
Shares Change (YoY)	+7.22%
Shares Change (QoQ)	-0.00%
Owned by Insiders (%)	4.02%
Owned by Institutions (%)	27.92%
Float	5.44M

Valuation Ratios

The trailing PE ratio is 2.32.

PE Ratio	2.32
Forward PE	n/a
PS Ratio	n/a
Forward PS	n/a
PB Ratio	n/a
P/TBV Ratio	n/a
P/FCF Ratio	n/a
P/OCF Ratio	n/a
PEG Ratio	n/a

Enterprise Valuation

EV / Earnings	8.97
EV / Sales	n/a
EV / EBITDA	n/a
EV / EBIT	n/a
EV / FCF	n/a

Financial Position

The company has a current ratio of 9.21

Current Ratio	9.21
Quick Ratio	8.88
Debt / Equity	n/a
Debt / EBITDA	n/a
Debt / FCF	n/a
Interest Coverage	-8.25

Financial Efficiency

Return on Equity (ROE)	n/a
Return on Assets (ROA)	-28.61%
Return on Invested Capital (ROIC)	-30.35%
Return on Capital Employed (ROCE)	-61.81%
Revenue Per Employee	n/a
Profits Per Employee	$781,837
Employee Count	8
Asset Turnover	n/a
Inventory Turnover	n/a

Taxes

Income Tax	n/a
Effective Tax Rate	n/a

Stock Price Statistics

The stock price has decreased by -35.61% in the last 52 weeks. The beta is -0.34, so NERV's price volatility has been lower than the market average.

Beta (5Y)	-0.34
52-Week Price Change	-35.61%
50-Day Moving Average	1.78
200-Day Moving Average	1.95
Relative Strength Index (RSI)	51.57
Average Volume (20 Days)	20,930

Short Selling Information

The latest short interest is 28,259, so 0.40% of the outstanding shares have been sold short.

Short Interest	28,259
Short Previous Month	27,437
Short % of Shares Out	0.40%
Short % of Float	0.52%
Short Ratio (days to cover)	5.42

Income Statement

Revenue	n/a
Gross Profit	-9.09M
Operating Income	-19.07M
Pretax Income	-33.65M
Net Income	6.25M
EBITDA	-19.06M
EBIT	-19.07M
Earnings Per Share (EPS)	$0.83

Balance Sheet

The company has $17.29 million in cash and $60.00 million in debt, giving a net cash position of -$42.71 million or -$6.11 per share.

Cash & Cash Equivalents	17.29M
Total Debt	60.00M
Net Cash	-42.71M
Net Cash Per Share	-$6.11
Equity (Book Value)	-29.15M
Book Value Per Share	-4.17
Working Capital	15.98M

Cash Flow

Operating Cash Flow	-17.53M
Capital Expenditures	n/a
Free Cash Flow	-17.53M
FCF Per Share	-$2.51

Margins

Gross Margin	n/a
Operating Margin	n/a
Pretax Margin	n/a
Profit Margin	n/a
EBITDA Margin	n/a
EBIT Margin	n/a
FCF Margin	n/a

Dividends & Yields

NERV does not appear to pay any dividends at this time.

Dividend Per Share	n/a
Dividend Yield	n/a
Dividend Growth (YoY)	n/a
Years of Dividend Growth	n/a
Payout Ratio	n/a
Buyback Yield	-7.22%
Shareholder Yield	-7.22%
Earnings Yield	46.76%
FCF Yield	-131.05%

Analyst Forecast

The average price target for NERV is $5.00, which is 161.44% higher than the current price. The consensus rating is "Hold".

Price Target	$5.00
Price Target Difference	161.44%
Analyst Consensus	Hold
Analyst Count	1
Revenue Growth Forecast (5Y)	n/a
EPS Growth Forecast (5Y)	87.53%

Fair Value

There are several formulas that can be used to estimate the intrinsic value of a stock.

Lynch Fair Value	n/a
Lynch Upside	n/a
Graham Number	n/a
Graham Upside	n/a

Stock Splits

The last stock split was on June 21, 2022. It was a reverse split with a ratio of 1:8.

Last Split Date	Jun 21, 2022
Split Type	Reverse
Split Ratio	1:8

Scores

Altman Z-Score	n/a
Piotroski F-Score	2